Description

Nanoparticle (NP) based therapeutic and theranostic agents have been developed for various diseases, yet application to neural disease/injury is restricted by the blood-brain-barrier (BBB). Traumatic brain injury (TBI) results in

Nanoparticle (NP) based therapeutic and theranostic agents have been developed for various diseases, yet application to neural disease/injury is restricted by the blood-brain-barrier (BBB). Traumatic brain injury (TBI) results in a host of pathological alterations, including transient breakdown of the BBB, thus opening a window for NP delivery to the injured brain tissue. This study focused on investigating the spatiotemporal accumulation of different sized NPs after TBI.

Reuse Permissions
  • application/pdf

    Download count: 0

    Details

    Contributors
    Date Created
    • 2016-07-22
    Resource Type
  • Text
  • Collections this item is in
    Identifier
    • Digital object identifier: 10.1038/srep29988
    • Identifier Type
      International standard serial number
      Identifier Value
      2045-2322
    Note

    Citation and reuse

    Cite this item

    This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.

    Bharadwaj, V. N., Lifshitz, J., Adelson, P. D., Kodibagkar, V. D., & Stabenfeldt, S. E. (2016). Temporal assessment of nanoparticle accumulation after experimental brain injury: Effect of particle size. Scientific Reports, 6(1). doi:10.1038/srep29988

    Machine-readable links